Full COVID-19 vaccine courses could be available for the entire global adult population by the end of 2021

More than 14 billion doses (including 2020 doses) are planned for 2021, enough for six billion individuals—assuming that all innovators’ vaccines are successful and require two doses.

Public announcements indicate target global vaccine-manufacturing capacity of more than 14 billion doses by end of 2021.

To read the article, see “On pins and needles: Tracking COVID-19 vaccines and therapeutics,” February 18, 2021.